Corporate partnerships are key, Part II

In today's Motley Fool I had an article published entitled: A Ray of Hope for Flamel. Although I am a shareholder in Flamel, I am not overly optimistic about its future prospects for growth. About the only thing that will cause me to become more bullish is an announcement that a major pharmaceutical company has agreed to partner with Flamel in its use of Flamel's Medusa technology. The company's recent announcement that its technology has demonstrated positive results means very little.

My point -- and I can't stress this enough to would-be investors -- is that for the majority of nanotechnology companies partnerships are more important than technology. They are even more important than having a viable product.

Jack Uldrich

Related Links:
Corporate partnerships are key